Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Maxime Duijst"'
Autor:
Leonie Voorwerk, Joyce Sanders, Milou S. Keusters, Sara Balduzzi, Sten Cornelissen, Maxime Duijst, Esther H. Lips, Gabe S. Sonke, Sabine C. Linn, Hugo M. Horlings, Marleen Kok
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-10 (2023)
Abstract Immune checkpoint blockade (ICB) is currently approved for patients with triple-negative breast cancer (TNBC), whereas responses to ICB are also observed in a small subgroup of Estrogen Receptor (ER)-positive breast cancer. The cut-off for E
Externí odkaz:
https://doaj.org/article/bf1f76273f634aa69a34a1e2029a1773
Autor:
Eleonora E. Lambert, Véronique Corbière, Jacqueline A. M. van Gaans-van den Brink, Maxime Duijst, Prashanna Balaji Venkatasubramanian, Elles Simonetti, Martijn Huynen, Dimitri D. Diavatopoulos, Pauline Versteegen, Guy A. M. Berbers, Françoise Mascart, Cécile A. C. M. van Els
Publikováno v:
Vaccines, Vol 8, Iss 2, p 225 (2020)
To advance research and development of improved pertussis vaccines, new immunoassays are needed to qualify the outcome of Bordetella pertussis (Bp) specific CD4+ T-cell differentiation. Here, we applied a recently developed whole blood assay to evalu
Externí odkaz:
https://doaj.org/article/c54012acc6204f1692b6ab1253111a9c
Autor:
Olga S. Blomberg, Lorenzo Spagnuolo, Hannah Garner, Leonie Voorwerk, Olga I. Isaeva, Ewald van Dyk, Noor Bakker, Myriam Chalabi, Chris Klaver, Maxime Duijst, Kelly Kersten, Marieke Brüggemann, Dorien Pastoors, Cheei-Sing Hau, Kim Vrijland, Elisabeth A.M. Raeven, Daphne Kaldenbach, Kevin Kos, Inna S. Afonina, Paulien Kaptein, Louisa Hoes, Willemijn S.M.E. Theelen, Paul Baas, Emile E. Voest, Rudi Beyaert, Daniela S. Thommen, Lodewyk F.A. Wessels, Karin E. de Visser, Marleen Kok
Publikováno v:
CANCER CELL
Immune checkpoint blockade (ICB) has heralded a new era in cancer therapy. Research into the mechanisms underlying response to ICB has predominantly focused on T cells; however, effective immune responses require tightly regulated crosstalk between i
Autor:
Olga S, Blomberg, Lorenzo, Spagnuolo, Hannah, Garner, Leonie, Voorwerk, Olga I, Isaeva, Ewald, van Dyk, Noor, Bakker, Myriam, Chalabi, Chris, Klaver, Maxime, Duijst, Kelly, Kersten, Marieke, Brüggemann, Dorien, Pastoors, Cheei-Sing, Hau, Kim, Vrijland, Elisabeth A M, Raeven, Daphne, Kaldenbach, Kevin, Kos, Inna S, Afonina, Paulien, Kaptein, Louisa, Hoes, Willemijn S M E, Theelen, Paul, Baas, Emile E, Voest, Rudi, Beyaert, Daniela S, Thommen, Lodewyk F A, Wessels, Karin E, de Visser, Marleen, Kok
Publikováno v:
Cancer cell.
Immune checkpoint blockade (ICB) has heralded a new era in cancer therapy. Research into the mechanisms underlying response to ICB has predominantly focused on T cells; however, effective immune responses require tightly regulated crosstalk between i
Autor:
Dimitri D Diavatopoulos, Eleonora E. Lambert, Cécile A. C. M. van Els, Maxime Duijst, Véronique Corbière, Prashanna Balaji Venkatasubramanian, Martijn A. Huynen, Pauline Versteegen, Françoise Mascart, Elles Simonetti, Jacqueline A. M. van Gaans-van den Brink, Guy A. M. Berbers
Publikováno v:
Vaccines (Basel), 8
Vaccines
Volume 8
Issue 2
Vaccines, 8 (2
Vaccines, Vol 8, Iss 225, p 225 (2020)
Vaccines (Basel), 8, 2
Vaccines
Volume 8
Issue 2
Vaccines, 8 (2
Vaccines, Vol 8, Iss 225, p 225 (2020)
Vaccines (Basel), 8, 2
To advance research and development of improved pertussis vaccines, new immunoassays are needed to qualify the outcome of Bordetella pertussis (Bp) specific CD4+ T-cell differentiation. Here, we applied a recently developed whole blood assay to evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9eb4fd5fe9dd58004ff6c52638f4f18
http://hdl.handle.net/2066/220858
http://hdl.handle.net/2066/220858
Autor:
Gerben Ferwerda, Oliver Wicht, Willem Luytjes, Elisabeth A. van Erp, Dorien Feyaerts, Puck B. van Kasteren, Maxime Duijst, H. Lie Mulder
Publikováno v:
The Journal of Infectious Diseases, 219, 5, pp. 723-733
The Journal of Infectious Diseases
The Journal of Infectious Diseases, 219, 723-733
The Journal of Infectious Diseases
The Journal of Infectious Diseases, 219, 723-733
Background Respiratory syncytial virus (RSV) is a major cause of severe acute lower respiratory tract infections in infants. Natural killer (NK) cells are important antiviral effector cells that likely encounter RSV in the presence of virus-specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfa8f8a68c49304ae2772729d5751778
https://doi.org/10.1093/infdis/jiy566
https://doi.org/10.1093/infdis/jiy566